Before 2010, higher-income taxpayers were subject to a phase-out rule that curtailed deductions for personal and dependent exemptions. That rule was gone for 2010, 2011 and 2012 but is back for 2013 and beyond.
Irish drugmaker Shire Pharmaceuticals has been ordered to pay a $56.5 million fine to settle claims that it exaggerated the benefits of several of its drugs, including Adderall XR and Vyvanse, both used to treat attention deficit hyperactivity disorder (ADHD).
Adderall is a combination drug containing salts of the two enantiomers of amphetamine, a psychostimulant of the phenethylamine class. Adderall is prescribed in the treatment of attention deficit hyperactivity disorder (ADHD) and narcolepsy. It is also used as an athletic performance and cognitive enhancer, and recreationally as an aphrodisiac and euphoriant.